Wegovy HD (Semaglutide 7.2 mg): FDA Approval, STEP UP Trial Data, and What It Means for Weight Loss Treatment

Wegovy HD (semaglutide 7.2 mg) launched in the U.S. this week after FDA approval in just 54 days. The STEP UP trial showed 20.7% mean weight loss — with 1 in 3 patients losing 25% or more of body weight.

Read more

Support ✨
📞 Call
Hi there! Want to chat via voice? Click the Call button! 😊
🤖
Listening...
Speak naturally with the agent
📞